Trial Profile
Pharmacokinetic and safety study of plitidepsin in patients with advanced cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Aug 2019
Price :
$35
*
At a glance
- Drugs Plitidepsin (Primary)
- Indications Cancer
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 13 Feb 2017 New trial record
- 23 Jan 2017 Results published in the Investigational New Drugs